An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation
Clinical trial NCT02590432 · COMPLETED
Trial details
- NCT number
- NCT02590432
- Sponsor
- Forest Laboratories
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2018-02-05
- Enrollment
- 828
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.